CD8A and COVID-19: Cumulated reports evidenced that some patients with severe COVID-19 might display a syndrome with a distinct cytokine storm [5,6], reduction in CD8+ cell [7], and acute lung injury (ALI) associated with pulmonary inflammation and increased microvascular permeability [8].